EGFR and hypertrophic cardiomyopathy: KEGG pathway analysis revealed that the upregulated DEOSGs were mainly enriched in diabetic cardiomyopathy, leishmaniasis, leukocyte transendothelial migration, and atherosclerosis (Figure 2(c)), and the downregulated DEOSGs were mainly enriched in longevity regulating pathway-multiple species, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor resistance, hypertrophic cardiomyopathy, and MAPK signaling pathway (Figure 2(e)).